BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 26018084)

  • 1. Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb.
    Nakashima M; Saitsu H; Takei N; Tohyama J; Kato M; Kitaura H; Shiina M; Shirozu H; Masuda H; Watanabe K; Ohba C; Tsurusaki Y; Miyake N; Zheng Y; Sato T; Takebayashi H; Ogata K; Kameyama S; Kakita A; Matsumoto N
    Ann Neurol; 2015 Sep; 78(3):375-86. PubMed ID: 26018084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
    Lim JS; Kim WI; Kang HC; Kim SH; Park AH; Park EK; Cho YW; Kim S; Kim HM; Kim JA; Kim J; Rhee H; Kang SG; Kim HD; Kim D; Kim DS; Lee JH
    Nat Med; 2015 Apr; 21(4):395-400. PubMed ID: 25799227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.
    Mirzaa GM; Campbell CD; Solovieff N; Goold C; Jansen LA; Menon S; Timms AE; Conti V; Biag JD; Adams C; Boyle EA; Collins S; Ishak G; Poliachik S; Girisha KM; Yeung KS; Chung BHY; Rahikkala E; Gunter SA; McDaniel SS; Macmurdo CF; Bernstein JA; Martin B; Leary R; Mahan S; Liu S; Weaver M; Doerschner M; Jhangiani S; Muzny DM; Boerwinkle E; Gibbs RA; Lupski JR; Shendure J; Saneto RP; Novotny EJ; Wilson CJ; Sellers WR; Morrissey M; Hevner RF; Ojemann JG; Guerrini R; Murphy LO; Winckler W; Dobyns WB
    JAMA Neurol; 2016 Jul; 73(7):836-845. PubMed ID: 27159400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain somatic mutations in MTOR leading to focal cortical dysplasia.
    Lim JS; Lee JH
    BMB Rep; 2016 Feb; 49(2):71-2. PubMed ID: 26779999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR pathway activation in focal cortical dysplasia.
    Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M
    Ann Diagn Pathol; 2020 Jun; 46():151523. PubMed ID: 32325422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.
    Patil VV; Guzman M; Carter AN; Rathore G; Yoshor D; Curry D; Wilfong A; Agadi S; Swann JW; Adesina AM; Bhattacharjee MB; Anderson AE
    Neuropathology; 2016 Apr; 36(2):146-56. PubMed ID: 26381727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.
    Lim JS; Gopalappa R; Kim SH; Ramakrishna S; Lee M; Kim WI; Kim J; Park SM; Lee J; Oh JH; Kim HD; Park CH; Lee JS; Kim S; Kim DS; Han JM; Kang HC; Kim HH; Lee JH
    Am J Hum Genet; 2017 Mar; 100(3):454-472. PubMed ID: 28215400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, imaging, and immunohistochemical characteristics of focal cortical dysplasia Type II extratemporal epilepsies in children: analyses of an institutional case series.
    Knerlich-Lukoschus F; Connolly MB; Hendson G; Steinbok P; Dunham C
    J Neurosurg Pediatr; 2017 Feb; 19(2):182-195. PubMed ID: 27885945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR.
    Leventer RJ; Scerri T; Marsh AP; Pope K; Gillies G; Maixner W; MacGregor D; Harvey AS; Delatycki MB; Amor DJ; Crino P; Bahlo M; Lockhart PJ
    Neurology; 2015 May; 84(20):2029-32. PubMed ID: 25878179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activation of mTOR in maldeveloped balloon cells and dysmorphic neurons of type II focal cortical dysplasia].
    Lin K; Lin YX; Kang DZ; Ye ZX; Wang XF
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):311-5. PubMed ID: 24004587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.
    D'Gama AM; Geng Y; Couto JA; Martin B; Boyle EA; LaCoursiere CM; Hossain A; Hatem NE; Barry BJ; Kwiatkowski DJ; Vinters HV; Barkovich AJ; Shendure J; Mathern GW; Walsh CA; Poduri A
    Ann Neurol; 2015 Apr; 77(4):720-5. PubMed ID: 25599672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations.
    Baulac S; Ishida S; Marsan E; Miquel C; Biraben A; Nguyen DK; Nordli D; Cossette P; Nguyen S; Lambrecq V; Vlaicu M; Daniau M; Bielle F; Andermann E; Andermann F; Leguern E; Chassoux F; Picard F
    Ann Neurol; 2015 Apr; 77(4):675-83. PubMed ID: 25623524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balloon cells promote immune system activation in focal cortical dysplasia type 2b.
    Zimmer TS; Broekaart DWM; Luinenburg M; Mijnsbergen C; Anink JJ; Sim NS; Michailidou I; Jansen FE; van Rijen PC; Lee JH; François L; van Eyll J; Dedeurwaerdere S; van Vliet EA; Mühlebner A; Mills JD; Aronica E
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):826-839. PubMed ID: 34003514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinico-pathological characterisation of focal cortical dysplasia type IIb genetically defined by MTOR mosaicism.
    Wang Y; Yu T; Blümcke I; Cai Y; Sun K; Gao R; Wang Y; Fu Y; Wang W; Wang Y; Zhang G; Piao Y
    Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12874. PubMed ID: 36544434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial omics reveals molecular changes in focal cortical dysplasia type II.
    Vermeulen I; Rodriguez-Alvarez N; François L; Viot D; Poosti F; Aronica E; Dedeurwaerdere S; Barton P; Cillero-Pastor B; Heeren RMA
    Neurobiol Dis; 2024 Jun; 195():106491. PubMed ID: 38575092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain Somatic Mutations in MTOR Disrupt Neuronal Ciliogenesis, Leading to Focal Cortical Dyslamination.
    Park SM; Lim JS; Ramakrishina S; Kim SH; Kim WK; Lee J; Kang HC; Reiter JF; Kim DS; Kim HH; Lee JH
    Neuron; 2018 Jul; 99(1):83-97.e7. PubMed ID: 29937275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar PDK1-AKT-mTOR pathway activation in balloon cells and dysmorphic neurons of type II focal cortical dysplasia with refractory epilepsy.
    Lin YX; Lin K; Kang DZ; Liu XX; Wang XF; Zheng SF; Yu LH; Lin ZY
    Epilepsy Res; 2015 May; 112():137-49. PubMed ID: 25847349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
    Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal cortical dysplasia: Updates.
    Pinheiro J; Honavar M
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S189-S197. PubMed ID: 35562149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal malformations of cortical development: new vistas for molecular pathogenesis.
    Lim KC; Crino PB
    Neuroscience; 2013 Nov; 252():262-76. PubMed ID: 23892008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.